Company: NPO
Filing Date: 2025-03-24
Form Type: DEF 14A
Source: 0001171200-25-000088
Chunk: 57

Company: Enpro Inc.
Filing Date: 2025-03-24
Form: DEF 14A
Chunk 57
---
 the pay ratio reported by other companies may not be comparable to the amounts reported above, as other companies may have different employment and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.

| 2025            
 PROXY STATEMENT | 57 | ENPRO 
 INC.  |

Proposal 3—Approval of an amendment and restatement of our 2020 Equity Compensation Plan (Item 3 on the proxy card) The board of directors is submitting a proposal for approval by the shareholders of an amendment and restatement of our 2020 Equity Compensation Plan, which is set forth in our Amended and Restated 2020 Equity Compensation Plan included in Appendix B. The 2020 Equity Compensation Plan was approved by the shareholders in 2020 and replaced our Amended and Restated 2002 Equity Compensation Plan (the “Prior Plan”). In this section of the proxy statement, we refer to our Amended and Restated 2020 Equity Compensation Plan as the “Equity Plan.” The amendments effected by the Equity Plan would increase the number of shares of our common stock issuable in connection with awards under the Equity Plan by 400,000 shares. In addition, the amendments would (i) extend the term under which awards may be made under the Equity Plan from April 29, 2030 to April 30, 2035, (ii) revise certain of the share counting provisions, and(iii) make certain clarifications and otherwise update the Equity Plan for changes since 2020. Our board of directors believes the Equity Plan is an important factor in attracting, keeping and motivating key employees, and further believes that the type of incentive compensation offered under the Equity Plan should continue to be offered in the future. The following general discussion of the Equity Plan, including the increase in the number of shares and other changes reflected in the proposed amendment and restatement, is qualified by reference to the copy of the Equity Plan that is attached to this proxy statement as Appendix B. The board approved the Equity Plan, subject to shareholder approval, at its February 13, 2025 meeting. Key features The following features of the Equity Plan protect the interests of our shareholders:

| · | Limitation                                                                        
 on terms of stock options and stock appreciation rights. The maximum term of each 
 stock option and stock appreciation right, or SAR, is ten (10) years.             |

| · | No                                                                                              
 repricing or grant of discounted stock options or SARs. The Equity Plan